Age: 8.0
Sex: F
Vaccine: HPV4, HPV9, HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Product Lot number issue; No adverse side effects were reported. No additional AE/No PQC.; HCP called regarding a patient who was vaccinated with GARDASIL 9 today, 7/18/2024 at 9 years old. HCP just realized the child was vaccinated last year at 8 years old, before the recommended dosing for GARDASIL 9 (previous vaccine on 5/17/2023).; The patient chart had an incorrect date of birth at well visit on 17-MAY-2023. Gardasil #1 ordered and administered.; HCP called regarding a patient who was vaccinated with GARDASIL 9 today, 7/18/2024 at 9 years old. HCP just realized the child was vaccinated last year at 8 years old, before the recommended dosing for GARDASIL 9 (previous vaccine on 5/17/2023).; This spontaneous report was received from a registered nurse and referred to an 8-year-old female patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 17-MAY-2023, at 8 years old, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), lot #W014479, (expiration date: 16-DEC-2024), administered intramuscularly for prophylaxis (strength, dose and anatomical location were not provided) (Reporter also reported this vaccine as quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine [GARDASIL] with lot # W014479 which was not valid for quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine [GARDASIL]. However, lot # W014479 is valid for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) [GARDASIL 9] as previously reported, conflicting information) (Product lot number issue). This vaccine was administered outside of prescribing information in error, the patient's chart had an incorrect date of birth at well visit, and the vaccine was ordered and administered (Product administered to patient of inappropriate age, Circumstance or information capable of leading to medication error). This event had not been reported previously.  On 18-JUL-2024 at the age of 9 years old, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), lot #2032274, (expiration date: 19-JAN-2026), administered for prophylaxis (strength, dose, and route of administration were not provided) (Inappropriate schedule of product administration). On this date, the health care professional (HCP) realized the child was vaccinated last year at 8 years old, before the recommended dosing for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (as previously reported). On this date, the child had a well exam and informed the office of the incorrect of birth in chart. Consequently, the provider recognized the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (also reported as quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine [GARDASIL], conflicting information) was given early and family made aware. No adverse side effects were reported. No additional information available the reporting time. No additional adverse event (AE)/No product quality complaint (PQC).